Βιβλιογραφική αναφορά:
Aboraya, A., Rankin, E., France, C., El-Missiry, A., & John, C. (2006). The Reliability of Psychiatric Diagnosis Revisited: The Clinician’s Guide to Improve the Reliability of Psychiatric Diagnosis. Psychiatry (Edgmont (Pa.: Township)), 3(1), 41–50.
Acker, B., Harris, A., & Oldham, A. J. (1957). Insulin treatment of schizophrenia; a controlled study. Lancet (London, England), 272(6969), 607–611. https://doi.org/10.1016/s0140-6736(57)91070-xAllbutt, C. (1924). Hippocrates – Hippocrates. With English Translation by W. H. S. Jones, St. Catherine’s College, Cambridge (Loeb Classical Library.) Vol. II. Pp. lvi 336: London: Heinemann; New York: G. P. Putnam’s Sons, 1923. – Hippocrates and his Successors in Relation to the Philosophy of their Time. By R. O. Moon, M.D., F.R.C.P. The Fitzpatrick Lectures, R.C.P., 1921–22. London: Longmans, 1923. 6s. The Classical Review, 38(7-8), 175-177. doi:10.1017/S0009840X00040361
Andreasen, N. C. (1985). The broken brain: the biological revolution in psychiatry. New York, Harper & Row.
Ang, B., Horwitz, M., & Moncrieff, J. (2022). Is the chemical imbalance an ‘urban legend’? an exploration of the status of the serotonin theory of depression in the scientific literature. SSM – Mental Health, 2, 100098. https://doi.org/10.1016/j.ssmmh.2022.100098
Angell M. (2000). Is academic medicine for sale?. The New England journal of medicine, 342(20), 1516–1518. https://doi.org/10.1056/NEJM200005183422009
American Psychiatric Association. (1952). Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association.
American Psychiatric Association. (1968). Diagnostic and statistical manual of mental disorders. (2nd edition). Washington, DC: American Psychiatric Association.
American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders. (3nd edition). Washington, DC: American Psychiatric Association.
American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders. (3nd ed., revised). Washington, DC: American Psychiatric Association.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders. (4nd edition). Washington, DC: American Psychiatric Association.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders. (4nd ed., text revision). Washington, DC: American Psychiatric Association.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: American Psychiatric Association. https://doi.org/10.1176/appi.books.9780890425596
Amsterdam, J. D., McHenry, L. B., & Jureidini, J. N. (2017). Industry-corrupted psychiatric trials. Zjawisko korupcji w badaniach psychiatrycznych. Psychiatria polska, 51(6), 993–1008. https://doi.org/10.12740/PP/80136
Andrews, P. W., Thomson, J. A., Jr, Amstadter, A., & Neale, M. C. (2012). Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good. Frontiers in psychology, 3, 117. https://doi.org/10.3389/fpsyg.2012.00117
Artico, M., Spoletini, M., Fumagalli, L., Biagioni, F., Ryskalin, L., Fornai, F., Salvati, M., Frati, A., Pastore, F. S., & Taurone, S. (2017). Egas Moniz: 90 Years (1927-2017) from Cerebral Angiography. Frontiers in neuroanatomy, 11, 81. https://doi.org/10.3389/fnana.2017.00081
Arroll, B., Elley, C. R., Fishman, T., Goodyear-Smith, F. A., Kenealy, T., Blashki, G., Kerse, N., & Macgillivray, S. (2009). Antidepressants versus placebo for depression in primary care. The Cochrane database of systematic reviews, 2009(3), CD007954. https://doi.org/10.1002/14651858.CD007954
Baldessarini, R., J. (2000). American Biological Psychiatry and Psychopharmacology, 1944 – 1994. In American Psychiatry after World War II: 1944 – 1994, edited by Menninger, R., W., & Nemiah, J., C.
Washington, DC: American Psychiatric Press
Barrowman, N. (2014). Correlation, Causation, and Confusion. The New Atlantis, 43, 23–44. http://www.jstor.org/stable/43551404
Bateson, G. (2017). Βήματα για μια οικολογία του νου. (μτφ. Ε., Σαμαρά). University Studio Press. (Έτος έκδοσης πρωτότυπου 1972)
Bernardo, Á., del Vayo, M. Á., Gavilanes, M. Á., Tuñas, O., & Cabo, D. (2021, March 9). Pay up or put it off: How europe treats depression and anxiety. Civio. https://civio.es/medicamentalia/2021/03/09/access-to-mental-health-in-europe/
Bateson, G., Jackson, D. D., Haley, J., & Weakland, J. (1956). Toward a theory of schizophrenia. Behavioral Science, 1, 251–264. https://doi.org/10.1002/bs.3830010402
Beer M. D. (1996). Psychosis: a history of the concept. Comprehensive psychiatry, 37(4), 273–291. https://doi.org/10.1016/s0010-440x(96)90007-3
Brax, H., Fadlallah, R., Al-Khaled, L., Kahale, L. A., Nas, H., El-Jardali, F., & Akl, E. A. (2017). Association between physicians’ interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis. PloS one, 12(4), e0175493. https://doi.org/10.1371/journal.pone.0175493
Breggin, P. R. (1997). Brain-disabling treatments in psychiatry: Drugs, electroshock, and the role of the FDA. Springer Publishing Co.
Brennan, T. A., Rothman, D. J., Blank, L., Blumenthal, D., Chimonas, S. C., Cohen, J. J., Goldman, J., Kassirer, J. P., Kimball, H., Naughton, J., & Smelser, N. (2006). Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA, 295(4), 429–433. https://doi.org/10.1001/jama.295.4.429
Bourne, H. (1953). The insulin myth. Lancet (London, England), 265(6793), 964–968. https://doi.org/10.1016/s0140-6736(53)90622-9
Bunney, W. E., & Davis, J. M. (1965). Norepinephrine in depressive reactions. Archives of General Psychiatry, 13(6), 483–494. https://doi.org/10.1001/archpsyc.1965.01730060001001
Burton, R. (1628). The anatomy of melancholy: What it is, with all the kinds, causes, symptomes, prognostickes, & seuerall cures of it: In three partitions, with their severall sections, members & subsections philosophically, medicinally, historically opened & cut vp / by Democritus Junior ; with a satyricall preface, conducing to the (The thirde edition, corrected and augmented by the author ed.).
Cassidy, W. L., Flanagan, N. B., Spellman, M., & Cohen, M. E. (1957). Clinical observations in manic-depressive disease. Journal of the American Medical Association, 164, 1535–1546.
Clayton, P. J., & Lewis, C. E. (1981). The significance of secondary depression. Journal of affective disorders, 3(1), 25–35. https://doi.org/10.1016/0165-0327(81)90016-1
Cozens, C. (2002, October 23). Europe rejects drug advertising. The Guardian. https://www.theguardian.com/media/2002/oct/23/advertising.marketingandpr
Coppen, A. (1967). The Biochemistry of Affective Disorders. The British Journal of Psychiatry, 113(504), 1237-1264. doi:10.1192/bjp.113.504.1237
Davis, G. (2012). The most deadly disease of asylumdom: General paralysis of the insane and scottish psychiatry, c.1840–1940. The Journal of the Royal College of Physicians of Edinburgh, 42(3), 266–273. https://doi.org/10.4997/jrcpe.2012.316
Deacon, B. J. (2013). The biomedical model of mental disorder: A critical analysis of its validity, utility, and effects on psychotherapy research. Clinical Psychology Review, 33(7), 846–861. https://doi.org/10.1016/j.cpr.2012.09.007
del Vayo, M. Á., Bernardo, Á., & Tuñas, O. (2021, April 30). Antidepressant use in Europe continues to break records. Civio. https://civio.es/medicamentalia/2021/04/30/antidepressant-use-in-europe-continues-to-break-records/
Demasi, M., & Gøtzsche, P. C. (2020). Presentation of benefits and harms of antidepressants on websites: A cross-sectional study. The International journal of risk & safety in medicine, 31(2), 53–65. https://doi.org/10.3233/JRS-191023
Diaz, J. A., Griffith, R. A., Ng, J. J., Reinert, S. E., Friedmann, P. D., & Moulton, A. W. (2002). Patients’ use of the Internet for medical information. Journal of general internal medicine, 17(3), 180–185. https://doi.org/10.1046/j.1525-1497.2002.10603.x
Dreyfus, G. (1907). Die Melancholie Ein Zustandsbild des Manisch-depressiven Irreseins: Eine klinische Studie. Jena, Germany: Gustav Fischer.
Engel G. L. (1977). The need for a new medical model: a challenge for biomedicine. Science (New York, N.Y.), 196(4286), 129–136. https://doi.org/10.1126/science.847460
Eurostat. (2021, September 10). 7.2% of people in the EU suffer from Chronic Depression. 7.2% of people in the EU suffer from chronic depression – Products Eurostat News – Eurostat. https://ec.europa.eu/eurostat/web/products-eurostat-news/-/edn-20210910-1
European monitoring center for drugs and drug addiction (χ.η.). Benzodiazepines drug profile. Ανακτήθηκε στις 10/07/2023. https://www.emcdda.europa.eu/publications/drug-profiles/benzodiazepines_en
Eysenck, H. (1970). The Classification of Depressive Illnesses. The British Journal of Psychiatry, 117(538), 241-250. doi:10.1192/S0007125000193195
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Jr, Winokur, G., & Munoz, R. (1972). Diagnostic criteria for use in psychiatric research. Archives of general psychiatry, 26(1), 57–63. https://doi.org/10.1001/archpsyc.1972.01750190059011
Feighner, J. P. (1989). The advent of the Feighner Criteria. Citation Classics, 43, 14.
Feyerabend, P. (2008). Against method. Verso. (Έτος έκδοσης πρωτότυπου 1975).
Fischer, M. A., Keough, M. E., Baril, J. L., Saccoccio, L., Mazor, K. M., Ladd, E., Von Worley, A., & Gurwitz, J. H. (2009). Prescribers and pharmaceutical representatives: why are we still meeting?. Journal of general internal medicine, 24(7), 795–801. https://doi.org/10.1007/s11606-009-0989-6
First, M.B., Gaebel, W., Maj, M., Stein, D.J., Kogan, C.S., Saunders, J.B., Poznyak, V.B., Gureje, O., Lewis-Fernández, R., Maercker, A., Brewin, C.R., Cloitre, M., Claudino, A., Pike, K.M., Baird, G., Skuse, D., Krueger, R.B., Briken, P., Burke, J.D., Lochman, J.E., Evans, S.C., Woods, D.W. and Reed, G. (2021), An organization- and category-level comparison of diagnostic requirements for mental disorders in ICD-11 and DSM-5. World Psychiatry, 20: 34-51. https://doi.org/10.1002/wps.20825
Foerster, H. von. (2003). Understanding understanding: Essays on cybernetics and Cognition (2003rd ed.). Springer-Verlag.
Foucault, M. (2004). Η Ιστορία της Τρέλας. (μτφ. Αμπατζοπούλου, Φ.) Εκδόσεις Ηριδανός (Έτος έκδοσης πρωτότυπου 1964).
Fretheim, A., & Oxman, A. D. (2005). International variation in prescribing antihypertensive drugs: its extent and possible explanations. BMC health services research, 5(1), 21. https://doi.org/10.1186/1472-6963-5-21
Freud, S. (1922). Mourning and Melancholia. Journal of Nervous and Mental Disease, 56, 543-545.
Fugh-Berman, A., & Ahari, S. (2007). Following the script: how drug reps make friends and influence doctors. PLoS medicine, 4(4), e150. https://doi.org/10.1371/journal.pmed.0040150
Gabe J. (1990). Towards a sociology of tranquillizer prescribing. British journal of addiction, 85(1), 41–48. https://doi.org/10.1111/j.1360-0443.1990.tb00622.x
Gagnon, M. A., & Lexchin, J. (2008). The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS medicine, 5(1), e1. https://doi.org/10.1371/journal.pmed.0050001
Gartlehner, G., & Stepper, K. (2012). Julius Wagner-Jauregg: pyrotherapy, simultanmethode, and ‘racial hygiene’. Journal of the Royal Society of Medicine, 105(8), 357–359. https://doi.org/10.1258/jrsm.2012.12k0049
Goffman, E. (1986). Stigma: Notes on the management of spoiled identity (Reissue edition). A Touchstone Book. (Έτος έκδοσης πρωτότυπου 1963).
Goodman, A. B., Rahav, M., Popper, M., Ginath, Y., & Pearl, E. (1984). The reliability of psychiatric diagnosis in Israel’s Psychiatric Case Register. Acta psychiatrica Scandinavica, 69(5), 391–397. https://doi.org/10.1111/j.1600-0447.1984.tb02510.x
Healy D. (1987). The structure of psychopharmacological revolutions. Psychiatric developments, 5(4), 349–376.
Healy, D. (2003). The antidepressant era. Harvard university press. ((Έτος έκδοσης πρωτότυπου 1997).
Healy D. (2004). Shaping the intimate: influences on the experience of everyday nerves. Social studies of science, 34(2), 219–245. https://doi.org/10.1177/0306312704042620
Hill, K. P., Ross, J. S., Egilman, D. S., & Krumholz, H. M. (2008). The ADVANTAGE seeding trial: a review of internal documents. Annals of internal medicine, 149(4), 251–258. https://doi.org/10.7326/0003-4819-149-4-200808190-00006
Hoffman, B. (2014). An overview of depression among transgender women. Depression Research and Treatment, 2014, 1–9. https://doi.org/10.1155/2014/394283
Horwitz, A. V., & Wakefield, J. C. (2007). The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. Oxford University Press.
Horwitz A. V. (2010). How an age of anxiety became an age of depression. The Milbank quarterly, 88(1), 112–138. https://doi.org/10.1111/j.1468-0009.2010.00591.x
Horwitz, A. V. (2011). Creating an Age of Depression: The Social Construction and Consequences of the Major Depression Diagnosis. Society and Mental Health, 1(1), 41-54. https://doi.org/10.1177/2156869310393986
Horwitz, A. V., Wakefield, J. C., & Lorenzo-Luaces, L. (2017). History of Depression. Στο DeRubeis, R. J. & Strunk, D. R. (eds), The Oxford Handbook of Mood Disorders, Oxford Library of Psychology (2017; online ed, Oxford Academic, 5 Oct. 2015), (part II, chapter II, σελ. 11 – 23). https://doi.org/10.1093/oxfordhb/9780199973965.001.0001
Horwitz, Allan V., Jerome C. Wakefield, and Lorenzo Lorenzo-Luaces, ‘History of Depression’, in Robert J. DeRubeis, and Daniel R. Strunk (eds), The Oxford Handbook of Mood Disorders, Oxford Library of Psychology (2017; online edn, Oxford Academic, 5 Oct. 2015), https://doi.org/10.1093/oxfordhb/9780199973965.013.2
Hyman, S. E., & Nestler, E. J. (1996). Initiation and adaptation: a paradigm for understanding psychotropic drug action. The American journal of psychiatry, 153(2), 151–162. https://doi.org/10.1176/ajp.153.2.151
Jauhar, S., Arnone, D., Baldwin, D. S., Bloomfield, M., Browning, M., Cleare, A. J., Corlett, P., Deakin, J. F. W., Erritzoe, D., Fu, C., Fusar-Poli, P., Goodwin, G. M., Hayes, J., Howard, R., Howes, O. D., Juruena, M. F., Lam, R. W., Lawrie, S. M., McAllister-Williams, H., Marwaha, S., … Cowen, P. J. (2023). A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression. Molecular psychiatry, 28(8), 3149–3152. https://doi.org/10.1038/s41380-023-02095-y
Joint Action on Mental Health and Well-being. (2017). Joint Action on Mental Health and well-being – public health. https://health.ec.europa.eu/document/download/ab5ab6a0-b8a5-47a7-9c81-91a0183c3a19_en
Kendell, R. (1976). The Classification of Depressions: A Review of Contemporary Confusion. The British Journal of Psychiatry, 129(1), 15-28. doi:10.1192/bjp.129.1.15
Kendler K. S. (1990). Toward a scientific psychiatric nosology. Strengths and limitations. Archives of general psychiatry, 47(10), 969–973. https://doi.org/10.1001/archpsyc.1990.01810220085011
Kendler, K. S., Muñoz, R. A., & Murphy, G. (2010). The development of the Feighner criteria: a historical perspective. The American journal of psychiatry, 167(2), 134–142. https://doi.org/10.1176/appi.ajp.2009.09081155
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., Wang, P. S., & National Comorbidity Survey Replication (2003). The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA, 289(23), 3095–3105. https://doi.org/10.1001/jama.289.23.3095
Kessler, R.C. et al. (2007). Age of onset of mental disorders: A review of recent literature, Current Opinion in Psychiatry, 20(4), pp. 359–364. doi:10.1097/yco.0b013e32816ebc8c.
Kessler, D. A., Rose, J. L., Temple, R. J., Schapiro, R., & Griffin, J. P. (1994). Therapeutic-class wars – drug promotion in a competitive marketplace. The New England journal of medicine, 331(20), 1350–1353. https://doi.org/10.1056/NEJM199411173312007
Kiloh, L. G., & Garside, R. F. (1963). The independence of neurotic depression and endogenous depression. The British journal of psychiatry : the journal of mental science, 109, 451–463. https://doi.org/10.1192/bjp.109.461.451
Kirsch, I. (2009). The emperor’s new drugs: Exploding the antidepressant myth (1st ed.). Basic Books.
Kirsch, I. (2011). Robert Whitaker, anatomy of an epidemic: Magic Bullets, psychiatric drugs, and the astonishing rise of Mental Illness in America. The American Journal of Psychology, 124(3), 372–374. https://doi.org/10.5406/amerjpsyc.124.3.0372
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008). Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS medicine, 5(2), e45. https://doi.org/10.1371/journal.pmed.0050045
Kirsch, I., Moore, T. J., Scoboria, A., & Nicholls, S. S. (2002). The emperor’s new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prevention & Treatment, 5(1), Article 23. https://doi.org/10.1037/1522-3736.5.1.523a
Kitamura, T., Shima, S., Sakio, E., & Kato, M. (1989). Psychiatric diagnosis in Japan. 2. Reliability of conventional diagnosis and discrepancies with Research Diagnostic Criteria diagnosis. Psychopathology, 22(5), 250–259. https://doi.org/10.1159/000284605
Kolb, L., C., Frazier, S., H., & Sirovatka, P., (2000). The National Institute of Mental Health: Its Influence on Mental Health. In American Psychiatry after World War II: 1944 – 1994, edited by Menninger, R., W., & Nemiah, J., C.
Washington, DC: American Psychiatric Press
Koo, M. M., Krass, I., & Aslani, P. (2003). Factors influencing consumer use of written drug information. The Annals of pharmacotherapy, 37(2), 259–267. https://doi.org/10.1177/106002800303700218
Kraepelin, E (1899). Psychiatrie. Ein Lehrbuch für Studierende und Ärzte: Zweiter Band. Verlag der Wissenshaften.
Kraepelin, E. (1962). One hundred years of psychiatry. Citadel. (Έτος έκδοσης πρωτότυπου 1918).
Kraepelin, E. (1976). Manic-depressive insanity and paranoia (R. M. Barclay, Trans.). New York, NY: Arno Press (Έτος έκδοσης πρωτότυπου 1921).
Kramer, P. D. (1997). Listening to Prozac. Penguin Books.
Kuhn, T. S. (2015). The structure of Scientific Revolutions. The University of Chicago Press. (Έτος έκδοσης πρωτότυπου 1962).
Lacasse, J. R., & Leo, J. (2005). Serotonin and depression: A disconnect between the advertisements and the scientific literature. PLoS Medicine, 2(12). https://doi.org/10.1371/journal.pmed.0020392
Lacasse, J. R., & Leo, J. (2015). Antidepressants and the chemical imbalance theory of depression: A reflection and update on the discourse. the Behavior Therapist, 38(7), 206–213.
Larkin, J., Pericin, I., Collins, M., Smith, S. M., Byrne, D., & Moriarty, F. (2021). GPs’ perceptions of their relationship with the pharmaceutical industry: a qualitative study. BJGP open, 5(5), BJGPO.2021.0057. https://doi.org/10.3399/BJGPO.2021.0057
Lebowitz, M. S., & Appelbaum, P. S. (2019). Biomedical Explanations of Psychopathology and Their Implications for Attitudes and Beliefs About Mental Disorders. Annual review of clinical psychology, 15, 555–577. https://doi.org/10.1146/annurev-clinpsy-050718-095416
Lehmann, P. (2013). Wie aktuell ist eigentlich noch Franco Basaglia? – Psychiater, Psychotherapeuten und die reduzierte Lebenserwartung psychiatrischer Patienten. Psychotherapie-Wissenschaft, 3(2), 79–89.
Lehmann, P. (2022). Επιστροφή του Ηλεκτροσόκ. Θεραπεία ή βλάβη; Νησίδες
Leo, J., & Lacasse, J. R. (2007). The media and the chemical imbalance theory of depression. Society, 45(1), 35–45. https://doi.org/10.1007/s12115-007-9047-3
Lewinsohn, P. (1998). Major depressive disorder in older adolescentsprevalence, risk factors, and clinical implications. Clinical Psychology Review, 18(7), 765–794. https://doi.org/10.1016/s0272-7358(98)00010-5
Lexchin J. (1997). What information do physicians receive from pharmaceutical representatives?. Canadian family physician Medecin de famille canadien, 43, 941–945.
Logan, J. (2022, December 1). Democratizing Psychiatric Knowledge Production through lived experience leadership. Mad In America. Ανακτήθηκε στις 19/01/2024 https://www.madinamerica.com/2022/03/democratizing-psychiatric-knowledge-production-lived-experience-leadership/
López-Muñoz, F., & Alamo, C. (2009). Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Current pharmaceutical design, 15(14), 1563–1586. https://doi.org/10.2174/138161209788168001
Linu, D., Vidhya, W., & Onkar, S. (2022, February). Antidepressant drugs market statistics: Forecast – 2030. Allied Market Research. https://www.alliedmarketresearch.com/antidepressants-drugs-market
Lipsman, N., & Lozano, A. M. (2011). The most cited works in major depression: the ‘Citation classics’. Journal of affective disorders, 134(1-3), 39–44. https://doi.org/10.1016/j.jad.2011.05.031
Malhi, G. S., & Mann, J. J. (2018). Depression. The Lancet, 392(10161), 2299–2312. https://doi.org/10.1016/s0140-6736(18)31948-2
March, R. J., & Geloso, V. (2020). Gordon Tullock meets Phineas Gage: The political economy of lobotomies in the United States. Research Policy, 49(1), 103872. https://doi.org/10.1016/j.respol.2019.103872
McDaid, D., & Park, A-La, (2011, January 4). (PDF) Online Health: Untangling the web – researchgate. http://www.bupa.com/healthpulse. https://www.researchgate.net/publication/232041614_Online_Health_Untangling_the_Web
Miller, G. A. (2010). Mistreating Psychology in the Decades of the Brain. Perspectives on Psychological Science, 5(6), 716–743. https://doi.org/10.1177/1745691610388774
Mintzes, B., Barer, M. L., Kravitz, R. L., Bassett, K., Lexchin, J., Kazanjian, A., Evans, R. G., Pan, R., & Marion, S. A. (2003). How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne, 169(5), 405–412.
Mojtabai R. (2008). Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychotherapy and psychosomatics, 77(2), 83–92. https://doi.org/10.1159/000112885
Moncrieff J. (2008). The creation of the concept of an antidepressant: an historical analysis. Social science & medicine (1982), 66(11), 2346–2355. https://doi.org/10.1016/j.socscimed.2008.01.047
Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horwitz, M. A. (2022). The serotonin theory of depression: A Systematic Umbrella Review of the evidence. Molecular Psychiatry. https://doi.org/10.1038/s41380-022-01661-0
Moncrieff, J., Cooper, R.E., Stockmann, T. et al. (2023) The serotonin hypothesis of depression: both long discarded and still supported?. Molecular Psychiatry. https://doi.org/10.1038/s41380-023-02094-z
Moncrieff, J. (2022a). Ο μύθος της χημικής ίασης. Μια κριτική της ψυχιατρικής φαρμακοθεραπείας. (μτφ. Η. Γιαννόπουλος). Εκδόσεις Oposito. (Έτος έκδοσης πρωτότυπου 2008).
Moncrieff, J. (2022b). The political economy of the Mental Health System: A Marxist analysis. Frontiers in Sociology, 6. https://doi.org/10.3389/fsoc.2021.771875
Murphy, J. M., Olivier, D. C., Monson, R. R., Sobol, A. M., & Leighton, A. H. (1988). Incidence of depression and anxiety: the Stirling County Study. American journal of public health, 78(5), 534–540. https://doi.org/10.2105/ajph.78.5.534
Murphy, J. M., & Leighton, A. H. (2009). Anxiety: its role in the history of psychiatric epidemiology. Psychological medicine, 39(7), 1055–1064. https://doi.org/10.1017/S0033291708004625Murphy, J. M., Olivier, D. C., Monson, R. R., Sobol, A. M., & Leighton, A. H. (1988). Incidence of depression and anxiety: the Stirling County Study. American journal of public health, 78(5), 534–540. https://doi.org/10.2105/ajph.78.5.534
Marcus, S. C., & Olfson, M. (2010). National trends in the treatment for depression from 1998 to 2007. Archives of general psychiatry, 67(12), 1265–1273. https://doi.org/10.1001/archgenpsychiatry.2010.151
Meek, C. (2006). SSRI ads questioned. Canadian Medical Association Journal, 174(6), 754–754. https://doi.org/10.1503/cmaj.051634
OECD/EU (2018), Health at a Glance: Europe 2018: State of Health in the EU Cycle, OECD Publishing, Paris. https://doi.org/10.1787/health_glance_eur-2018-en
Olfson, M., Marcus, S. C., Druss, B., Elinson, L., Tanielian, T., & Pincus, H. A. (2002). National trends in the outpatient treatment of depression. JAMA, 287(2), 203–209. https://doi.org/10.1001/jama.287.2.203
Paykel, E. (1971). Classification of Depressed Patients: A Cluster Analysis Derived Grouping. The British Journal of Psychiatry, 118(544), 275-288. doi:10.1192/bjp.118.544.275
Pearce, J. M. S. (2012). Brain disease leading to mental illness: A concept initiated by the discovery of general paralysis of the insane. European Neurology, 67(5), 272–278. https://doi.org/10.1159/000336538
Pescosolido, B. A., Martin, J. K., Long, J. S., Medina, T. R., Phelan, J. C., & Link, B. G. (2010). “A disease like any other”? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. American Journal of Psychiatry, 167(11), 1321–1330. https://doi.org/10.1176/appi.ajp.2010.09121743
Pew Research Center. (2013, February 12). The internet and health. Pew Research Center: Internet, Science & Tech. https://www.pewresearch.org/internet/2013/02/12/the-internet-and-health/
Pies, R. W. (2011, July 11). Psychiatry’s new brain-mind and the legend of the “chemical imbalance.” Psychiatric Times. https://www.psychiatrictimes.com/view/psychiatrys-new-brain-mind-and-legend-chemical-imbalance
Pilkington, P. D., Reavley, N. J., & Jorm, A. F. (2013). The Australian public’s beliefs about the causes of depression: Associated Factors and changes over 16 years. Journal of Affective Disorders, 150(2), 356–362. https://doi.org/10.1016/j.jad.2013.04.019
Pincus, H. A., Henderson, B., Blackwood, D., & Dial, T. (1993). Trends in research in two general psychiatric journals in 1969-1990: research on research. The American journal of psychiatry, 150(1), 135–142. https://doi.org/10.1176/ajp.150.1.135
Popper, K. (1959). The logic of scientific discovery. Basic Books.
Rabkin, J. G., Markowitz, J. S., Stewart, J., McGrath, P., Harrison, W., Quitkin, F. M., & Klein, D. F. (1986). How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine. Psychiatry research, 19(1), 75–86. https://doi.org/10.1016/0165-1781(86)90094-6
Raz, M. (2009). Psychosurgery, industry and Personal Responsibility, 1940-1965. Social History of Medicine, 23(1), 116–133. https://doi.org/10.1093/shm/hkp061
Raz, M. (2014, January 18). Looking back: Interpreting lobotomy – the patients’ stories. BPS. https://www.bps.org.uk/psychologist/looking-back-interpreting-lobotomy-patients-stories
Read, J., & Harré, N. (2001). The role of biological and genetic causal beliefs in the stigmatisation of “mental patients’. Journal of Mental Health, 10(2), 223–235. https://doi.org/10.1080/09638230123129
Read, J., Haslam, N., Sayce, L., & Davies, E. (2006). Prejudice and schizophrenia: a review of the ‘mental illness is an illness like any other’ approach. Acta psychiatrica Scandinavica, 114(5), 303–318. https://doi.org/10.1111/j.1600-0447.2006.00824.x
Read, J., Renton, J., Harrop, C., Geekie, J., & Dowrick, C. (2020). A survey of UK General Practitioners About Depression, antidepressants and withdrawal: Implementing the 2019 Public Health England Report. Therapeutic Advances in Psychopharmacology, 10, 204512532095012. https://doi.org/10.1177/2045125320950124
Read, J., & Law, A. (1999). The relationship of causal beliefs and contact with users of mental health services to attitudes to the ‘mentally ill’. The International journal of social psychiatry, 45(3), 216–229. https://doi.org/10.1177/002076409904500309
Retzer, A. (2021). Συστημική οικογενειακή θεραπεία των ψυχώσεων. (μτφ. Α. Εμμανουηλίδου) Εκδόσεις Νησίδες. (Έτος έκδοσης πρωτότυπου 2004).
Rosenblatt, S., Chanley, J. D., Sobotka, H., & Kaufman, M. R. (1960). Interrelationships between electroshock, the blood-brain barrier, and catecholamines. Journal of neurochemistry, 5, 172–176. https://doi.org/10.1111/j.1471-4159.1960.tb13350.x
Rosenhan, D. L. (1973). On being sane in insane places. Science, 179(4070), 250–258. https://doi.org/10.1126/science.179.4070.250
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., Ritz, L., Biggs, M. M., Warden, D., Luther, J. F., Shores-Wilson, K., Niederehe, G., Fava, M., & STAR*D Study Team (2006). Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. The New England journal of medicine, 354(12), 1231–1242. https://doi.org/10.1056/NEJMoa052963
Sabshin M. (1990). Wendepunkte in der amerikanischen Psychiatrie des 20. Jahrhunderts [Turning points in American psychiatry of the 20th century]. Fortschritte der Neurologie-Psychiatrie, 58(9), 323–331. https://doi.org/10.1055/s-2007-1001195
Salmasi, S., Ming, L. C., & Khan, T. M. (2016). Interaction and medical inducement between pharmaceutical representatives and physicians: a meta-synthesis. Journal of pharmaceutical policy and practice, 9, 37. https://doi.org/10.1186/s40545-016-0089-z
Schildkraut, J. J. (1965). The catecholamine hypothesis of Affective Disorders: A review of supporting evidence. American Journal of Psychiatry, 122(5), 509–522. https://doi.org/10.1176/ajp.122.5.509
Schlippe, A. von, & Schweitzer, J. (2008). Εγχειρίδιο της συστημικής θεραπείας και συμβουλευτικής. University Studio Press.
Schreiber, R., & Hartrick, G. (2002). Keeping it together: how women use the biomedical explanatory model to manage the stigma of depression. Issues in mental health nursing, 23(2), 91–105. https://doi.org/10.1080/016128402753542749
Scull, A. (2014a). Cultural sociology of mental illness: An A-to-Z guide. SAGE Reference.
Scull A. (1994b). Somatic treatments and the historiography of psychiatry. History of psychiatry, 5(17 Pt 1), 1–12. https://doi.org/10.1177/0957154X9400501701
Sears, R. (2022, December 1). Did psychiatry ever endorse the chemical imbalance theory of depression?. Mad In America. https://www.madinamerica.com/2022/04/psychiatry-ever-endorse-chemical-imbalance-theory-depression/
Shorter, E. (1992). From paralysis to fatigue: A history of psychosomatic illness in the modern era. The Free Press.
Sismondo S. (2007). Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry?. PLoS medicine, 4(9), e286. https://doi.org/10.1371/journal.pmed.0040286
Sismondo S. (2016). Εισαγωγή στις Σπουδές Επιστήμης και Τεχνολογίας. Εκδόσεις Liberal Books
Sluzki, C. E., & Ramson, D. C. (1976). Double bind. Grune & Stratton.
Stastny, P., Lehmann, P. & Εμμανουηλίδου, Α. (2012). Αντί της Ψυχιατρικής: Εναλλακτικά μοντέλα συναντήσεις με τον ψυχικό πόνο. Εκδόσεις Νησίδες.
Tan, S. Y., & Yip, A. (2014). António Egas Moniz (1874-1955): Lobotomy pioneer and Nobel laureate. Singapore medical journal, 55(4), 175–176. https://doi.org/10.11622/smedj.2014048
Tone, A., & Koziol, M. (2018). (F)ailing women in psychiatry: lessons from a painful past. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne, 190(20), E624–E625. https://doi.org/10.1503/cmaj.171277
Tsay C. J. (2013). Julius Wagner-Jauregg and the legacy of malarial therapy for the treatment of general paresis of the insane. The Yale journal of biology and medicine, 86(2), 245–254.
United Kingdom Parliament. (2005, March 22). House of Commons, Health Committee. The Influence of the Pharmaceutical Industry. House of Commons Health Committee – publications.parliament.uk. Ανακτήθηκε στις 18/01/2024. https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/42.pdf
Valenstein, E. S. (1998). Blaming the brain: The truth about drugs and mental health. Free Press.
Wakefield, J. C., Schmitz, M. F., First, M. B., & Horwitz, A. V. (2007). Extending the bereavement exclusion for major depression to other losses: evidence from the National Comorbidity Survey. Archives of general psychiatry, 64(4), 433–440. https://doi.org/10.1001/archpsyc.64.4.433
Walker, I., & Read, J. (2002). The differential effectiveness of psychosocial and biogenetic causal explanations in reducing negative attitudes toward “mental illness”. Psychiatry, 65(4), 313–325. https://doi.org/10.1521/psyc.65.4.313.20238
Watzlawick, P., Bavelas, J. B., & Jackson, D. D. (2014). Pragmatics of human communication: A study of interactional patterns, pathologies, and paradoxes. W.W. Norton & Company. (Έτος έκδοσης πρωτότυπου 1967).
World Health Organization, (χ.η.). Covid-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide. World Health Organization. Ανακτήθηκε στις 29/06/2023. https://www.who.int/news/item/02-03-2022-covid-19-pandemic-triggers-25-increase-in-prevalence-of-anxiety-and-depression-worldwide
World Health Organization, (χ.η.). Depressive disorder (depression). World Health Organization. Ανακτήθηκε στις 29/06/2023. https://www.who.int/news-room/fact-sheets/detail/depression
World Health Organization (2004) The global burden of disease. https://apps.who.int/iris/bitstream/handle/10665/43942/9789241563710_eng.pdf
World Health Organization, (2022). ICD-11: International classification of diseases (11th revision). https://icd.who.int/
World Health Organization, (2023, March). Mental health, human rights and legislation: Guidance and practice. World Health Organization. Ανακτήθηκε στις 19/01/2024. https://www.who.int/publications/i/item/9789240080737
Whitaker, R., (2002). Mad in America. Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally. Perseus Publishing, Κέιμπριτζ
Whitaker, R.B. (2005). Anatomy of an Epidemic: Psychiatric Drugs and the Astonishing Rise of Mental Illness in America. Ethical Human Sciences and Services, 7, 23 – 35.
Yanatma, S. (2023, September 9). Europe’s mental health in data: Which country is the most depressed? Euronews. https://www.euronews.com/next/2023/09/09/europes-mental-health-crisis-in-data-which-country-uses-the-most-antidepressants
Zajicek B. (2017). Banning the Soviet Lobotomy: Psychiatry, Ethics, and Professional Politics during Late Stalinism. Bulletin of the history of medicine, 91(1), 33–61. https://doi.org/10.1353/bhm.2017.0002
Σκαραγκάς, Δ (2010). Ο ευαίσθητος εγκέφαλος. Ιανός
Αφήστε μια απάντηση